Science-driven - commercially focused
Nanomerics are leaders in pharmaceutical nanotechnology. Our nanomedicines know-how and our proprietary technology platforms provide drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides.
Nanomerics commercializes the proprietary technology platform developed by the founding scientists Prof Ijeoma F Uchegbu and Prof Andreas G Schätzlein over the last 20 years at the University of Glasgow, Strathclyde University, the School of Pharmacy and University College London.
Founded in 2010 the company has obtained an exclusive license to the technology and since 2011 has focused on the development of a product pipeline based on the company's proprietary Molecular Envelope Technology (MET).